Cataract Clinical Trial
Official title:
Clinical Outcomes of Patients Bilaterally Implanted With the TECNIS® Symfony or TECNIS® Symfony Toric Extended Range of Vision IOL
In With increased patients' demand for a spectacle-free lifestyle and technological
advancements, cataract surgery with multifocal intraocular lens (IOL) implantation has become
an effective solution for correcting presbyopia in patients who want to maintain their full
range of vision.
Conventional bifocal IOLs used either refractive or diffractive optics to split the light and
create 2 principal focal points, thus providing functional vision at distance and near. This
simultaneous imaging principle produces a sharp image that is overlaid by a secondary blurred
out-of focus image, so these IOLs inherently produce a deterioration in contrast sensitivity
and unwanted photic phenomena such as glare and halos. Additionally, studies reported
insufficient intermediate vision with bifocal IOLs.
There is an increasing desire for spectacle independence at intermediate distance, especially
due to the increased use of computers and smartphones. Trifocal IOLs were introduced to the
market in 2010 and participants provide an additional, third focal point to improve
intermediate vision without compromising distance and near vision. However, participants are
still vulnerable to decreased contrast sensitivity and photic phenomena due to the IOL's
mechanism of splitting the light into discrete focal points.
An extended depth of focus (EDOF) technology was recently introduced with the aim to improve
intermediate vision while maintaining image contrast. The diffractive echelette design,
embedded on its posterior optical surface, extends the range of vision and the achromatic
technology reduces corneal chromatic aberrations to enhance retinal image quality and improve
contrast sensitivity. The elongated focus allows imaging in a continuous range of vision
without overlapping near and far images, and therefore theoretically would provide a more
consistent distance and intermediate vision with less dysphotopsia.
The aim of this study was to investigate the clinical outcome of patients bilaterally
implanted with either Tecnis Symfony or Tecnis Symfony toric extended range of vision IOLs
(Johnson & Johnson Vision, Santa Ana, CA, USA) in terms of visual performance at different
distances, spectacle independence, photic phenomena, and patient satisfaction.
Enrollment period : 18 months after IRB approval Participants : Patients who had
uncomplicated cataract surgery with binocular implantation of either Symfony (ZXR00) or
Symfony toric (ZXT) IOLs.
Methods: The postoperative examinations were performed at 4-8 weeks, and 4-6 months
postoperatively. Binocular corrected (CDVA) and uncorrected (UDVA) distance visual acuity was
assessed at 4 m using a Snellen chart. Binocular uncorrected intermediate visual acuity
(UIVA) at 70 cm and binocular uncorrected near visual acuity (UNVA) at 40 cm were assessed
using the Rosenbaum near vision card.
A subjective questionnaire on spectacle use, photic phenomena, and satisfaction was
administered to all patients. Patients were asked how often (never, occasionally, 50% of the
time, frequently) participants wear spectacles for near, intermediate, and distance
activities. Non-directed and directed questions were used with regard to visual symptoms.
Photic phenomena (halos, glare and starbursts) were graded as none, trace, mild, moderate, or
severe. Patients were asked to rate their level of satisfaction with distance, intermediate,
and near vision on a scale from 0 (completely dissatisfied) to 10 (completely satisfied).
Additionally, participants were asked whether participants would choose the same IOL again
and if participants would recommend the IOL to their friends and family. Surgeons were also
asked to rate their level of satisfaction on a scale from 0 to 10 in terms of the ease of
manipulation and implantation of the IOL and the visual performance of the IOL.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |